Cannabis Law
Federal Schedule I conflict, state licensing, banking challenges, workplace testing, and legalization trends.
Overview
Cannabis law exists at the intersection of conflicting federal and state legal regimes. Under federal law, marijuana remains classified as a Schedule I controlled substance under the Controlled Substances Act, making its manufacture, distribution, and possession federal crimes. However, as of 2025, over 20 states and the District of Columbia have legalized recreational marijuana for adults, and nearly 40 states have authorized medical marijuana programs.
This federal-state conflict creates unique legal challenges. The Cole Memorandum (2013, rescinded 2018) provided DOJ guidance deprioritizing federal marijuana enforcement in states with robust regulatory systems. Congress has annually enacted the Rohrabacher-Blumenauer Amendment, prohibiting the DOJ from using funds to interfere with state medical marijuana programs. The SAFE Banking Act, which would provide legal protections for financial institutions serving state-legal cannabis businesses, has passed the House multiple times but has not been enacted, leaving the cannabis industry operating primarily in cash.
State cannabis regulatory frameworks typically address licensing (cultivation, manufacturing, distribution, retail, testing), zoning and local control, product safety and testing requirements, seed-to-sale tracking systems, social equity programs, and taxation. Cannabis taxation varies from ad valorem taxes on retail price to weight-based taxes on wholesale product. Workplace drug testing, impaired driving detection, and cannabis use in the context of employment discrimination, child custody, and housing are areas of active legal development.
Key Statutes
| Statute | Citation | Summary |
|---|---|---|
| Controlled Substances Act — Schedule I (Marijuana) | 21 U.S.C. §§ 801–904 | Federal law classifying marijuana as a Schedule I controlled substance, prohibiting its manufacture, distribution, and possession. |
| Agriculture Improvement Act of 2018 (Hemp Legalization) | Pub. L. 115-334, § 10113 | Legalized industrial hemp (cannabis with less than 0.3% THC) at the federal level, removing it from the Controlled Substances Act and allowing regulated commercial production. |
| Rohrabacher-Blumenauer Amendment | Consolidated Appropriations Act (annual rider) | Congressional spending rider prohibiting DOJ from using funds to prevent states from implementing their own medical marijuana laws. |
Key Cases
Gonzales v. Raich
545 U.S. 1 (2005)
Held that Congress may prohibit local cultivation and use of marijuana under the Commerce Clause, even where state law permits it, as part of a comprehensive regulatory scheme.
United States v. Oakland Cannabis Buyers' Cooperative
532 U.S. 483 (2001)
Held that there is no medical necessity defense to the federal prohibition on manufacturing and distributing marijuana.
Standing Akimbo, LLC v. United States
955 F.3d 1146 (10th Cir. 2020)
Addressed IRS Section 280E, which prohibits state-legal cannabis businesses from deducting ordinary business expenses for federal tax purposes.
Key Regulations
DEA Registration and Scheduling Regulations
Drug Enforcement Administration (21 CFR Parts 1301–1321)
Federal regulations governing controlled substance scheduling, registration requirements, and enforcement procedures applicable to cannabis.
USDA Hemp Production Regulations
USDA Agricultural Marketing Service (7 CFR Part 990)
Federal regulations for domestic hemp production, including licensing, THC testing, disposal of non-compliant plants, and reporting requirements.
FinCEN BSA Guidance for Marijuana-Related Businesses
Financial Crimes Enforcement Network (FIN-2014-G001)
Guidance on Bank Secrecy Act compliance for financial institutions providing services to marijuana-related businesses, requiring enhanced due diligence and suspicious activity reporting.
Common Issues
- Federal-state legal conflict and preemption concerns
- Cannabis business licensing and regulatory compliance
- Banking access and Section 280E tax limitations
- Workplace drug testing policies and employee protections
- Cannabis-impaired driving detection and enforcement
- Social equity programs and expungement of prior convictions
- Interstate commerce restrictions and dormant Commerce Clause
- Landlord-tenant issues involving cannabis use and cultivation
State Variations
Cannabis law varies enormously by state. Legalization models range from full adult-use with commercial sales to medical-only to full prohibition. State licensing structures differ in the number and types of licenses, residency requirements, and license caps. Tax rates and structures vary widely — some states tax by weight at wholesale, others by retail price percentage, and some use a hybrid approach. Social equity provisions (priority licensing for communities disproportionately affected by prohibition) exist in some states but not others. Local control provisions allowing municipalities to prohibit or permit cannabis businesses differ by state. Employment protections for off-duty cannabis use have been enacted in several states. Homegrow allowances range from prohibited to 12+ plants per household.
Resources
National Conference of State Legislatures — Cannabis Laws
Comprehensive tracking of state cannabis legislation, including legalization status, regulatory frameworks, and policy analysis.
National Cannabis Industry Association (NCIA)
Trade association representing state-legal cannabis businesses, advocating for federal policy reform and providing industry resources.